Stockscreener 앱 받기
19.36
2.98%
0.56
시간 외 거래:
19.33
-0.03
-0.15%
전일 마감가:
$18.80
열려 있는:
$18.64
하루 거래량:
91,157
Relative Volume:
0.75
시가총액:
$169.49M
수익:
$123.24M
순이익/손실:
$136.00K
주가수익비율:
-968.00
EPS:
-0.02
순현금흐름:
$-148.99M
1주 성능:
+2.22%
1개월 성능:
+35.57%
6개월 성능:
+26.55%
1년 성능:
+7.56%
1일 변동 폭
$18.60
$19.69
1주일 범위
$17.82
$19.87
52주 변동 폭
$6.53
$26.40
Seres Therapeutics Inc Stock (MCRB) Company Profile
명칭
Seres Therapeutics Inc
전화
617 945 9626
주소
200 SIDNEY STREET, CAMBRIDGE, MA
MCRB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MCRB
Seres Therapeutics Inc
|
19.36 | 164.59M | 123.24M | 136.00K | -148.99M | -0.02 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Seres Therapeutics Inc Stock (MCRB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-08 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2024-10-24 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-06-26 | 재개 | Oppenheimer | Outperform |
| 2023-04-21 | 개시 | JP Morgan | Neutral |
| 2021-07-23 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-05-18 | 재개 | Goldman | Neutral |
| 2021-03-05 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2020-09-18 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2020-08-18 | 개시 | Piper Sandler | Overweight |
| 2020-08-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-08-11 | 업그레이드 | Jefferies | Hold → Buy |
| 2019-04-30 | 개시 | Jefferies | Hold |
| 2018-10-22 | 개시 | Chardan Capital Markets | Buy |
| 2017-10-13 | 개시 | Oppenheimer | Outperform |
| 2017-08-04 | 재확인 | H.C. Wainwright | Buy |
| 2017-02-01 | 재확인 | FBR & Co. | Outperform |
| 2016-08-12 | 재확인 | FBR Capital | Outperform |
| 2016-08-01 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2016-08-01 | 재확인 | H.C. Wainwright | Buy |
| 2016-07-29 | 재개 | H.C. Wainwright | Buy |
| 2016-03-30 | 개시 | FBR Capital | Outperform |
| 2016-03-03 | 개시 | Guggenheim | Buy |
| 2016-01-25 | 개시 | H.C. Wainwright | Buy |
| 2015-10-22 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2015-07-22 | 개시 | Canaccord Genuity | Buy |
| 2015-07-21 | 개시 | Goldman | Neutral |
| 2015-07-21 | 개시 | Leerink Partners | Outperform |
모두보기
Seres Therapeutics Inc 주식(MCRB)의 최신 뉴스
Seres Therapeutics Inc. stock outlook for YEAR2025 Retail Activity & Safe Investment Capital Preservation Plans - Newser
Evaluating Seres Therapeutics Inc. with trendline analysisDividend Hike & Reliable Trade Execution Plans - Newser
tick level data insight on seres therapeutics inc. volatility2025 Top Gainers & AI Enhanced Trading Alerts - Newser
What candlestick patterns are forming on Seres Therapeutics Inc.July 2025 Chart Watch & Free Weekly Chart Analysis and Trade Guides - Newser
Is it time to cut losses on Seres Therapeutics Inc.July 2025 Highlights & Daily Stock Trend Watchlist - Newser
Ranking Seres Therapeutics Inc. among high performing stocks via tools2025 Volatility Report & Free Technical Confirmation Trade Alerts - Newser
Pattern recognition hints at Seres Therapeutics Inc. upsideMarket Sentiment Summary & Stepwise Entry/Exit Trade Alerts - Newser
Visual analytics tools that track Seres Therapeutics Inc. performanceJuly 2025 Rallies & High Yield Stock Recommendations - Newser
Using Bollinger Bands to evaluate Seres Therapeutics Inc.Day Trade & Free Weekly Watchlist of Top Performers - Newser
Volume spikes in Seres Therapeutics Inc. stock – what they mean2025 Market Outlook & Fast Entry and Exit Trade Plans - Newser
Is There Enough Volume to Lift Seres Therapeutics Inc.July 2025 Outlook & Real-Time Buy Zone Alerts - beatles.ru
Has Seres Therapeutics Inc. formed a bullish divergenceIndex Update & Long-Term Growth Plans - Newser
Seres Therapeutics receives $50 million from Nestlé Health Science - MSN
Earnings visualization tools for Seres Therapeutics Inc.2025 Short Interest & Target Return Focused Stock Picks - Newser
What machine learning models say about Seres Therapeutics Inc.2025 Volatility Report & Stepwise Swing Trade Plans - Newser
Seres Therapeutics Inc. stock momentum explainedJuly 2025 Closing Moves & Verified Momentum Stock Ideas - Newser
How to integrate Seres Therapeutics Inc. into portfolio analysis tools - Newser
Is Seres Therapeutics Inc. still worth holding after the dipEarnings Beat & Verified High Yield Trade Plans - Newser
Tick level data insight on Seres Therapeutics Inc. volatilityJuly 2025 Drop Watch & Community Shared Stock Ideas - Newser
Is now a turning point for Seres Therapeutics Inc.July 2025 Analyst Calls & Daily Oversold Stock Bounce Ideas - Newser
Full technical analysis of Seres Therapeutics Inc. stock2025 Technical Patterns & Free Expert Approved Momentum Trade Ideas - Newser
Can Seres Therapeutics Inc. be the next market leaderPortfolio Value Report & Fast Moving Stock Watchlists - خودرو بانک
Custom strategy builders for tracking Seres Therapeutics Inc.Sell Signal & Stock Market Timing Techniques - Newser
Is Seres Therapeutics Inc. a good stock for dollar cost averaging2025 Macro Impact & Precise Swing Trade Entry Alerts - خودرو بانک
Is Seres Therapeutics Inc. affected by consumer sentimentTrend Reversal & Weekly High Return Stock Opportunities - خودرو بانک
How to read the order book for Seres Therapeutics Inc.Exit Point & Smart Investment Allocation Insights - Newser
What MACD signals say about Seres Therapeutics Inc.Gold Moves & Long-Term Growth Portfolio Plans - Newser
Statistical indicators supporting Seres Therapeutics Inc.’s strength2025 Support & Resistance & Stock Market Timing Techniques - Newser
Top chart patterns to watch in Seres Therapeutics Inc.July 2025 Review & Weekly Watchlist for Consistent Profits - Newser
What is Seres Therapeutics Inc. s debt to equity ratioQuarterly Earnings Summary & Weekly Hot Stock Watchlists - خودرو بانک
What moving averages say about Seres Therapeutics Inc.July 2025 Market Mood & AI Forecasted Stock Moves - Newser
Market Pulse: Is Seres Therapeutics Inc. backed by strong institutional buyingTrade Analysis Report & Target Return Focused Picks - خودرو بانک
Applying chart zones and confluence areas to Seres Therapeutics Inc.Weekly Volume Report & Real-Time Volume Analysis Alerts - Newser
Why Seres Therapeutics Inc. stock attracts strong analyst attention2025 Fundamental Recap & Weekly High Momentum Picks - Newser
Seres Therapeutics Inc (MCRB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Seres Therapeutics Inc 주식 (MCRB) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| DesRosier Thomas | See Remarks |
Aug 18 '25 |
Sale |
16.65 |
76 |
1,265 |
7,455 |
| Henn Matthew R | See Remarks |
Aug 18 '25 |
Sale |
16.65 |
73 |
1,215 |
4,548 |
| Young Teresa L. | See Remarks |
Aug 18 '25 |
Sale |
16.65 |
59 |
982 |
5,215 |
| Young Teresa L. | See Remarks |
May 16 '25 |
Sale |
7.28 |
63 |
459 |
5,044 |
| Shaff Eric D. | CEO and President |
May 16 '25 |
Sale |
7.28 |
220 |
1,602 |
10,102 |
| DesRosier Thomas | Chief Legal Officer and EVP |
May 15 '25 |
Sale |
7.28 |
79 |
575 |
7,287 |
| Henn Matthew R | See Remarks |
May 16 '25 |
Sale |
7.28 |
77 |
561 |
4,383 |
| Young Teresa L. | See Remarks |
Feb 18 '25 |
Sale |
0.81 |
3,338 |
2,704 |
97,536 |
| Henn Matthew R. | See Remarks |
Feb 18 '25 |
Sale |
0.81 |
3,953 |
3,204 |
84,443 |
| Shaff Eric D. | CEO and President |
Feb 18 '25 |
Sale |
0.81 |
12,726 |
10,314 |
192,039 |
1.40%
자본화:
|
볼륨(24시간):